K-RAS STATUS DOES NOT PREDICT SUCCESSFUL HEPATIC RESECTION OF COLORECTAL-CANCER METASTASIS

被引:0
|
作者
KASTRINAKIS, WV [1 ]
RAMCHURREN, N [1 ]
MAGGARD, M [1 ]
STEELE, G [1 ]
SUMMERHAYES, IC [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To establish whether specific K-ras alterations are predictive of less aggressive turner behavior and subsequently those patients who are most likely to benefit from resection of hepatic metastases from colorectal carcinoma. Design: Evaluation of long-term survivors of hepatic resection for metastases of colorectal carcinoma (median survival, 85 months). Results: DNA, extracted from 26 paraffin-embedded hepatic metastases from 19 patients, was analyzed using single-strand conformation polymorphism and direct sequence analysis of codons 12 and 13 of the K-ras gene. Seven of 19 patients were found to harbor K-uas mutations. A similar frequency and spectrum of K-uas mutational events was detected in 14 patients with shortterm survival following pathologic diagnosis of hepatic metastasis. Conclusions: Neither the presence of a K-vas mutational event nor the precise nucleotide change are predictive of less aggressive tumor behavior, and genetic alterations at this locus alone cannot be used to select patients undergoing resection of hepatic metastases from colorectal carcinoma.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [41] CLINICAL OUTCOMES IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH BEVACIZUMAB AND K-RAS MUTATION STATUS
    Luis, I. V.
    Ribeiro, J.
    Matias, M.
    Casanova, M.
    Semedo, M.
    Pereira, S.
    Miltenberger-Miltenyi, G.
    Castro, A.
    Costa, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 218 - 218
  • [42] Age-related and clinicopathological features of colorectal cancer associated with K-ras gene status
    Belyaeva A.V.
    Yanus G.A.
    Suspitsyn E.N.
    Zaitseva O.A.
    Yatsuk O.S.
    Moiseenko A.B.
    Gulyaev A.V.
    Imyanitov E.N.
    Advances in Gerontology, 2012, 2 (4) : 306 - 311
  • [43] Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status
    Cao, Dan
    Chen, Ye
    Tang, Yuan
    Peng, Xing-Chen
    Dong, Hang
    Li, Long-Hao
    Cheng, Ke
    Ge, Jun
    Liu, Ji-Yan
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [44] DNA methylation status in a promoter region of the K-RAS gene in patients with Colorectal Cancer.
    Alirio Herrera-Pulido, Jehison
    Ricaurte-Guerrero, Orlando
    Acosta-Forero, Jinneth
    Moreno-Acosta, Pablo
    Carolina Sanabria-Salas, Maria
    Arboleda-Granados, Humberto
    Hernandez, Gustavo
    Lucia Serrano-Lopez, Martha
    CANCER RESEARCH, 2020, 80 (23)
  • [45] The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status
    Garcia-Alfonso, Pilar
    Grande, Enrique
    Polo, Eduardo
    Afonso, Ruth
    Jose Reina, Juan
    Jorge, Monica
    Manuel Campos, Juan
    Martinez, Virginia
    Angeles, Cristina
    Montagut, Clara
    ANGIOGENESIS, 2014, 17 (04) : 805 - 821
  • [46] Mutation of β-Catenin Does Not Coexist with K-ras Mutation in Colorectal Tumorigenesis
    Kazuhisa Shitoh
    Koji Koinuma
    Taiji Furukawa
    Masaki Okada
    Hideo Nagai
    Digestive Diseases and Sciences, 2004, 49 : 1631 - 1633
  • [47] Mutation of β-catenin does not coexist with K-ras mutation in colorectal tumorigenesis
    Shitoh, K
    Koinuma, K
    Furukawa, T
    Okada, M
    Nagai, H
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (10) : 1631 - 1633
  • [48] Prognostic impact of K-RAS mutational status and primary tumor location in patients undergoing resection for colorectal cancer liver metastases: an update
    O'Connor, Juan M.
    Sanchez Loria, Fernando
    Ardiles, Victoria
    Grondona, Jorge
    Sanchez, Pablo
    Andriani, Oscar
    Fauda, Martin
    Brancato, Fernando
    Huertas, Eduardo
    Alvarez, Fernando
    de Santibanes, Eduardo
    FUTURE ONCOLOGY, 2019, 15 (27) : 3149 - 3157
  • [49] Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer
    Miyamoto, Yuji
    Akiyama, Takahiko
    Kato, Rikako
    Sawayama, Hiroshi
    Ogawa, Katsuhiro
    Yoshida, Naoya
    Baba, Hideo
    DISEASES OF THE COLON & RECTUM, 2023, 66 (08) : E809 - E817
  • [50] The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status
    Pilar García-Alfonso
    Enrique Grande
    Eduardo Polo
    Ruth Afonso
    Juan José Reina
    Mónica Jorge
    Juan Manuel Campos
    Virginia Martínez
    Cristina Ángeles
    Clara Montagut
    Angiogenesis, 2014, 17 : 805 - 821